These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18986800)

  • 1. Oesophageal toxicity and hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer.
    Tho LM; Mahmood R; Leitch M; Brisbane I; Kakumanu S; Mohammed N
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):74. PubMed ID: 18986800
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictors of acute esophagitis in lung cancer patients treated with concurrent three-dimensional conformal radiotherapy and chemotherapy.
    Rodríguez N; Algara M; Foro P; Lacruz M; Reig A; Membrive I; Lozano J; López JL; Quera J; Fernández-Velilla E; Sanz X
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):810-7. PubMed ID: 18755556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical investigation of weekly Carboplatin and Paclitaxel with concurrent radiation therapy for locally advanced non-small cell lung cancer].
    Mito A; Yamasaki M; Matsuura K; Kajihara T; Nitta T; Awaya H; Arita K; Kashiwado K; Ohashi N
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1653-6. PubMed ID: 19838022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of high-dose three-dimensional radiation therapy in the treatment of localised non-small-cell lung cancer.
    Bellière A; Girard N; Chapet O; Khodri M; Kubas A; Souquet PJ; Mornex F
    Cancer Radiother; 2009 Jul; 13(4):298-304. PubMed ID: 19525134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of acute radiation-induced esophagitis in non-small-cell lung cancer patients using the Lyman NTCP model.
    Zhu J; Zhang ZC; Li BS; Liu M; Yin Y; Yu JM; Luo LM; Shu HZ; De Crevoisier R
    Radiother Oncol; 2010 Dec; 97(3):449-54. PubMed ID: 21067834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of hypofractionated accelerated radiotherapy concurrent with chemotherapy for non-small cell carcinoma of the lung.
    Carruthers R; O'Rourke N; Mohammed N; Hicks J; Brisbane I
    Clin Oncol (R Coll Radiol); 2011 Oct; 23(8):561-2. PubMed ID: 21676603
    [No Abstract]   [Full Text] [Related]  

  • 7. Gender difference in treatment outcomes in patients with stage III non-small cell lung cancer receiving concurrent chemoradiotherapy.
    Sekine I; Sumi M; Ito Y; Tanai C; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
    Jpn J Clin Oncol; 2009 Nov; 39(11):707-12. PubMed ID: 19692418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with severe acute esophagitis from hyperfractionated radiotherapy with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Watkins JM; Wahlquist AE; Shirai K; Garrett-Mayer E; Aguero EG; Fortney JA; Sherman CA; Sharma AK
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1108-13. PubMed ID: 19084345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction chemoradiotherapy for superior sulcus non-small-cell lung cancer: an answer for few.
    Leo F; Solli P; Veronesi G; Catalano G; De Pas T; Petrella F; Spaggiari L
    J Clin Oncol; 2007 May; 25(15):2146; author reply 2147. PubMed ID: 17513829
    [No Abstract]   [Full Text] [Related]  

  • 10. The incidence of perioperative anastomotic complications after sleeve lobectomy is not increased after neoadjuvant chemoradiotherapy.
    Milman S; Kim AW; Warren WH; Liptay MJ; Miller C; Basu S; Faber LP
    Ann Thorac Surg; 2009 Sep; 88(3):945-50; discussion 950-1. PubMed ID: 19699925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Phase II study of synchronous three-dimensional conformal boost to the gross tumor volume for patients with unresectable Stage III non-small-cell lung cancer: results of Korean Radiation Oncology Group 0301 study.
    Cho KH; Ahn SJ; Pyo HR; Kim KS; Kim YC; Moon SH; Han JY; Kim HT; Koom WS; Lee JS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1397-404. PubMed ID: 19117690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation chemotherapy in multimodality therapy of non-small cell lung cancer.
    Vokes EE
    Front Radiat Ther Oncol; 1992; 26():64-71. PubMed ID: 1324877
    [No Abstract]   [Full Text] [Related]  

  • 13. Will future progress in non-small-cell lung cancer be step by step... or by leaps and bounds?
    Movsas B
    J Clin Oncol; 2005 Sep; 23(25):5859-61. PubMed ID: 16087952
    [No Abstract]   [Full Text] [Related]  

  • 14. Radiation dose escalation by percutaneous interstitial brachytherapy in locally advanced non-small cell lung cancer.
    Sharma DN; Bahl A; Thulkar S; Rath GK; Basu KS; Bansal A; Julka PK
    Indian J Chest Dis Allied Sci; 2009; 51(2):103-6. PubMed ID: 19445446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose fractionation and biological optimization in lung cancer.
    Trodella L; D'Angelillo RM; Ramella S; Ciresa M; Massaccesi M
    Rays; 2004; 29(3):319-26. PubMed ID: 15603304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient willingness to undergo chemotherapy and thoracic radiotherapy for locally advanced non-small cell lung cancer.
    Hirose T; Yamaoka T; Ohnishi T; Sugiyama T; Kusumoto S; Shirai T; Okuda K; Ohmori T; Adachi M
    Psychooncology; 2009 May; 18(5):483-9. PubMed ID: 18942662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non small-cell bronchial cancers: toxicity of the association radiotherapy-chemotherapy. Review of the literature].
    Mornex F; Danhier S; Van Houtte P
    Bull Cancer; 1994 Jan; 81(1):5-13. PubMed ID: 7949585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
    Tell R; Sederholm C; Klintenberg C; Franksson L; Brandén E; Hillerdal G; Lönn U; Lindén CJ; Ewers SB; Lamberg K; Mrazek E; Lödén B; Sjögren A; Linné T; Friesland S; Sirzén F
    Anticancer Res; 2008; 28(5B):2851-7. PubMed ID: 19031924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma.
    Koukourakis MI; Patlakas G; Froudarakis ME; Kyrgias G; Skarlatos J; Abatzoglou I; Bougioukas G; Bouros D
    Anticancer Res; 2007; 27(5B):3625-31. PubMed ID: 17972527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of locally advanced non-small cell lung cancer.
    Fidler MJ; Kim AW; Zusag T; Bonomi P
    Clin Adv Hematol Oncol; 2009 Jul; 7(7):455-64, 479-80. PubMed ID: 19701153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.